Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Genprex, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 42 | 43 | +1 |
| Shares | 4.40M | 4.47M | +64.6K (+1.5%) |
| Value | $6.11M | $6.29M | +$179.7K (+2.9%) |
New holders (6)
Institutions that held Genprex, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 73,556 | $104.0K | 0.00% |
| Simplex Trading, LLC | 22,757 | $32.0K | 0.00% |
| Jane Street Group, LLC | 19,927 | $28.0K | 0.00% |
| Citadel Advisors LLC | 14,180 | $21.0K | 0.00% |
| Two Sigma Securities, LLC | 13,949 | $20.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 12,301 | $17.0K | 0.00% |
Sold out (5)
Institutions that held Genprex, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Spire Wealth Management | 45,000 | $63.0K |
| HighTower Advisors, LLC | 32,079 | $44.0K |
| Virtu Financial LLC | 29,710 | $41.0K |
| Goldman Sachs Group Inc | 21,394 | $30.0K |
| Barclays PLC | 5,618 | $8.00K |